Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Similar documents
CCG 360 o stakeholder survey 2017/18

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

CCG 360 stakeholder survey 2017/18 National report NHS England Publications Gateway Reference: 08192

SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

A review of the role and costs of clinical commissioning groups

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper

Trafford CCG. CCG authorisation 360 o stakeholder survey report. Version 18 Internal Use Only Version 14 Internal Use Only

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Cheshire, Warrington and Wirral Area Team Commissioning for Value Pack

International Collaborative Initiative. Enhancing Foresight and Scenario Analysis for Global Food Systems

Innovations in Health: Approaches from the Regional Innovation Funds

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Understanding and demonstrating variation through use of national data tools

Before I talk through the strategy itself, I want to tell you more about why

Across the Divide Tackling Digital Exclusion in Glasgow. Douglas White

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Health Innovation Manchester

Eastern Cheshire CCG CCG 360 o Stakeholder Survey

Kernow CCG CCG 360 o Stakeholder Survey

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.

A Science & Innovation Audit for the West Midlands

Digital Health Startups A FirstWord ExpertViews Dossier Report

Special Eurobarometer 460. Summary. Attitudes towards the impact of digitisation and automation on daily life

12 April Fifth World Congress for Freedom of Scientific research. Speech by. Giovanni Buttarelli

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals

CCG 360 o Stakeholder Survey

Framework Programme 7

Accountable Officer Report

OECD-INADEM Workshop on

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2

Epilogue. Simona Rocchi Erasmus University, Centre for Environmental Studies, Rotterdam

EU s Innovative Medical Technology and EMA s Measures

Patient Choice and Resource Allocation Policy. NHS South Warwickshire Clinical Commissioning Group (the CCG)

Helping your business grow in the UK health system

Human factors and design in future health care

Implementation of Systems Medicine across Europe

The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges.

Information & Communication Technology Strategy

Swindon CCG CCG 360 o Stakeholder Survey

New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients?

Southwark CCG CCG 360 o Stakeholder Survey

2. Evidence themes and their importance along the development path

December Eucomed HTA Position Paper UK support from ABHI

Supporting Innovation through Regulation and Science

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Foresight for policy-making

JOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed

Rushcliffe CCG CCG 360 o Stakeholder Survey

ABHI Response to the Kennedy short study on Valuing Innovation

European Commission. 6 th Framework Programme Anticipating scientific and technological needs NEST. New and Emerging Science and Technology

Media Literacy Policy

Standing Committee on the Law of Patents Twenty-Sixth Session

Imagine your future lab. Designed using Virtual Reality and Computer Simulation

Herefordshire CCG Patient Choice and Resource Allocation Policy

Extract of Advance copy of the Report of the International Conference on Chemicals Management on the work of its second session

Ministerial Conference on Nuclear Science and Technology: Addressing Current and Emerging Challenges Vienna, November 2018

Andalusian Agency for Health Technology Assessment (AETSA)

PRIMARY CARE CO-COMMISSIONING

Security and Risk Assessment in GDPR: from policy to implementation

Medtronic Payer Solutions

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

Project Territorial Strategies for Innovation

SCIROCCO - Scaling Integrated Care in Context

Policies for the Commissioning of Health and Healthcare

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey

The Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program

Diffusion of Innovations Theory. 2 nd National Medicine Reconciliation Workshop - 6 September 2011

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Enhancing Government through the Transforming Application of Foresight

Population Based Needs Assessment for Specialised Palliative Care

Health & Social Care Industrial Innovation

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

Roadmap for European Universities in Energy December 2016

Standing Committee on the Law of Patents

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:

Higher Education Contribution to Health Science Innovation

EU Cooperation on Health Technology Assessment

Strategic Futures Planning

COMMISSION OF THE EUROPEAN COMMUNITIES

Joint Research Centre. The European Commission s in-house science service

Learning Lessons Abroad on Funding Research and Innovation. 29 April 2016

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Torsti Loikkanen, Principal Scientist, Research Coordinator VTT Innovation Studies

ARTEMIS The Embedded Systems European Technology Platform

Collaboration Agreement

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

GPC update on co-commissioning of primary care: Important Guidance for CCG member practices and LMCs

Transcription:

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow

The context Demographics On-going financial constraints Rising expectations Governments have tinkered but we now need serious debate about the radical options The aim of this report is therefore to contribute to a dialogue on a sustainable health service over the longer term

Background Focus on the challenges beyond QIPP What are the options going forward? Explore the trends associated with healthcare to determine the opportunities for securing a sustainable NHS. Constraints The NHS should continue to be free at the point of delivery To consider social care issues, but to focus the scenarios on healthcare The views expressed are not those of either NHS England or the Department of Health

Methodology Desktop exercise, workshop with key stakeholders, and interviews with senior healthcare representatives from within and outside of the NHS to determine the key strategic trends. Steering group discussion to determine the relative importance and uncertainty of each trend.

Importance Plotting the trends economic social regulatory technological Explosion of clinical information resulting from DNA testing, and new internal and external digital monitoring devices People taking personal responsibility for their own health Available funding Disease demographics, e.g. an increase in the percentage of elderly people, with more cancers and long term conditions to treat Increase in value based decisions, using improved outcome and cost information Impact of EU regulation Influencing healthcare policy Smaller, cheaper testing devices bring diagnostics from the hospital to the home DNA testing and proteome testing allow new and existing drugs and treatments to be tailored to individuals Increase in community power Surgical developments such as robotics and advances in minimally invasive techniques Regenerative medicine, including stem cell Implants and growing of replacement tissues Uncertainty

Workshop with key stakeholders to develop 4 outline scenarios Powerful and responsible users Motivated people and communities, taking responsibility for their own health, exercising choice & control over services Incremental use of new technology Radical use of new technology Powerful supply-side organisations Passive users content to be guided by strong professional Influence.

Powerful and responsible users Powerful supply-side organisations PLURAL PROVISION THE GADGET SHOW Incremental use of all technology STABILITY WITH INTEGRATION MODERN TRADITIONAL Radical use of all technology

The Gadget Show Public appetite for affordable healthcare technologies has fuelled a revolution in attitudes towards self-care and treatment Many GPs put out of business as self-diagnosis and treatment becomes common Centralised specialist acute care, DGHs in decline, only entrepreneurial NHS organisations have survived International communication standards allow devices to communicate online expertise accessed 24/7 Private sector provider brands become household names, especially in diagnostics and self-care Elderly and vulnerable unable to embrace new technologies increasingly forgotten

Plural Provision Many NHS Trusts slow to adopt the latest treatments Patients increasingly travel (physically or virtually) to more innovative NHS organisations for treatment, private sector and abroad More vulnerable or passive patients struggle to gain access to best healthcare as systems are more complex and harder to navigate. Partly offset by the emergence of a stronger community spirit voluntary organisations help. Widespread duplication and fragmentation of healthcare without a standardised communications platform

Stability with Integration Some aspects of NHS fossilised; duplication of many old fashioned services prevails Comparative stability of the system and need to improve productivity mean greater integration across community services and with acute trusts Dominance of fewer, more powerful NHS providers More personalised services, where integration has been successful, but those seeking latest treatments need to look outside the NHS Wide variations in service provision remain

Modern Traditional Strong NHS providers still have major influence on shaping healthcare delivery, using technologies to meet local needs and strengthen their own position Not all technologies are cost effective; tendency to buy the latest toy Treatment often delivered from large acute centres, in joint ventures with private sector Over the counter diagnostic and treatment technologies reduce need for GPs; some now specialised /-integrated into hospital outreach services Services for the vulnerable removed from large powerful providers, integrated with social care and commissioned by local authorities

Key discussion points 1 All four scenarios suggest that the acute care sector will continue to centralise, with many services provided at fewer sites. Nothing in the scenarios suggests that demand for home support, residential or nursing home placements will fall, even with increased use of new self-care technologies and a more engaged public.

Key discussion points 2 Rise of digital communication and treatment technologies, coupled with an improvement in software compatibility, will reinforce issues of information security and reliability. The regulation of information flows and quality, without stifling innovation will be challenging. None of the scenarios suggests that health inequalities will diminish in the future, although the classifications might change.

Key discussion points 3 Improving digital connectivity will enable collation and coordination of information from a wide range of sources, helping health and social care providers to deliver better integrated and seamless care. Where public engagement is high, commissioners may struggle to reconcile views across a large number of influential groups with different priorities.

Key discussion points 4 Opportunities to replace or complement clinician activity will increasingly emerge where clinical measurement can either be automatically or entered into a computer by the patient. DNA profiling and molecular monitoring will increasingly allow personalised drugs and treatments to improve patient outcomes and reduce complications. The extent to which provision of such risk profiling information results in changed behaviour of patients is not known.

Final thoughts We are not offering solutions our scenarios are pictures of possible futures to help dialogue Critical question how will each of these scenarios address the big current and upcoming NHS challenges? And what are the political and cost consequences of each scenario?